Page 37 - Read Online

Li et al. Hepatoma Res. 2025;11:25 https://dx.doi.org/10.20517/2394-5079.2025.63 Page 15 of 17

11. Puijk RS, Dijkstra M, van der Lei S, et al. The added value of transcatheter CT hepatic angiography (CTHA) image guidance in
percutaneous thermal liver ablation: an experts’ opinion pictorial essay. Cancers. 2024;16:1193. DOI PubMed PMC
12. Huang Q, Zeng Q, Long Y, et al. Fusion imaging techniques and contrast-enhanced ultrasound for thermal ablation of hepatocellular
carcinoma - a prospective randomized controlled trial. Int J Hyperthermia. 2019;36:1207-15. DOI PubMed
13. Qi X, Yang M, Ma L, et al. Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor
immune response. J Immunother Cancer. 2020;8:e001038. DOI PubMed PMC
14. Li M, Jiang A, Han H, et al. A trinity nano-vaccine system with spatiotemporal immune effect for the adjuvant cancer therapy after
radiofrequency ablation. ACS Nano. 2024;18:4590-612. DOI
15. Ao F, Li X, Tan Y, et al. STING agonist-based hydrogel enhances immune activation in synergy with radiofrequency ablation for
hepatocellular carcinoma treatment. J Control Release. 2024;369:296-308. DOI PubMed
16. Li X, Zhang Y, Li S, et al. Macrophage hitchhiking for systematic suppression in postablative multifocal HCC. Hepatology.
2025;81:44-59. DOI PubMed
17. Wu CY, Lin LY, Lee TY, et al. Clinical guidelines for early hepatocellular carcinoma treatment options: a systematic review and
bibliometric analysis. Int J Surg. 2024;110:7234-44. DOI PubMed PMC
18. Minami Y, Nishida N, Kudo M. Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI. World J
Gastroenterol. 2014;20:4160-6. DOI PubMed PMC
19. Yang Y, Chen Y, Ye F, et al. Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk
factors, patterns, and survival. Eur Radiol. 2021;31:3053-64. DOI PubMed
20. Ke S, Ding XM, Kong J, et al. Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual
hepatic VX2 carcinoma. J Transl Med. 2010;8:73. DOI PubMed PMC
21. Imajo K, Ogawa Y, Yoneda M, Saito S, Nakajima A. A review of conventional and newer generation microwave ablation systems for
hepatocellular carcinoma. J Med Ultrason. 2020;47:265-77. DOI PubMed
22. Tan J, Tang T, Zhao W, Zhang ZS, Xiao YD. Initial incomplete thermal ablation is associated with a high risk of tumor progression in
patients with hepatocellular carcinoma. Front Oncol. 2021;11:760173. DOI PubMed PMC
23. Bigos KJ, Quiles CG, Lunj S, et al. Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve
treatment outcome in solid tumours. Front Oncol. 2024;14:1331355. DOI PubMed PMC
24. Hernandez GA, Perera RM. Autophagy in cancer cell remodeling and quality control. Mol Cell. 2022;82:1514-27. DOI PubMed
PMC
25. Wang X, Deng Q, Feng K, et al. Insufficient radiofrequency ablation promotes hepatocellular carcinoma cell progression via
autophagy and the CD133 feedback loop. Oncol Rep. 2018;40:241-51. DOI PubMed PMC
26. Jondal DE, Thompson SM, Butters KA, et al. Heat stress and hepatic laser thermal ablation induce hepatocellular carcinoma growth:
role of PI3K/mTOR/AKT signaling. Radiology. 2018;288:730-8. DOI PubMed PMC
27. Jiang J, Chen S, Li K, et al. Targeting autophagy enhances heat stress-induced apoptosis via the ATP-AMPK-mTOR axis for
hepatocellular carcinoma. Int J Hyperthermia. 2019;36:499-510. DOI PubMed
28. Xu WL, Wang SH, Sun WB, et al. Insufficient radiofrequency ablation-induced autophagy contributes to the rapid progression of
residual hepatocellular carcinoma through the HIF-1α/BNIP3 signaling pathway. BMB Rep. 2019;52:277-82. DOI PubMed PMC
29. Yu ZJ, Guo SW, Wang BS, et al. Ruthenium complex suppresses proliferation of residual hepatocellular carcinoma after incomplete
radiofrequency ablation therapy. Recent Pat Anticancer Drug Discov. 2024;Epub ahead of print. DOI
30. Iwahashi S, Shimada M, Utsunomiya T, et al. Epithelial-mesenchymal transition-related genes are linked to aggressive local recurrence
of hepatocellular carcinoma after radiofrequency ablation. Cancer Lett. 2016;375:47-50. DOI PubMed
31. Zhang N, Wang L, Chai ZT, et al. Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of
hepatocellular carcinoma cell HCCLM3 via activating β-catenin signaling. PLoS One. 2014;9:e115949. DOI PubMed PMC
32. Zhang N, Li H, Qin C, et al. Insufficient radiofrequency ablation promotes the metastasis of residual hepatocellular carcinoma cells via
upregulating flotillin proteins. J Cancer Res Clin Oncol. 2019;145:895-907. DOI PubMed PMC
7
33. Zhu S, Wu Y, Zhang X, et al. Targeting N -methylguanosine tRNA modification blocks hepatocellular carcinoma metastasis after
insufficient radiofrequency ablation. Mol Ther. 2023;31:1596-614. DOI PubMed PMC
34. Tong Y, Yang H, Xu X, et al. Effect of a hypoxic microenvironment after radiofrequency ablation on residual hepatocellular cell
migration and invasion. Cancer Sci. 2017;108:753-62. DOI PubMed PMC
35. Ortmann BM, Taylor CT, Rocha S. Hypoxia research, where to now? Trends Biochem Sci. 2024;49:573-82. DOI PubMed
36. Li K, Niu Y, Yuan Y, et al. Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning
TGF-β signaling. Oncogene. 2022;41:3197-209. DOI PubMed
37. Kong J, Kong J, Pan B, et al. Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-
1α/VEGFA. PLoS One. 2012;7:e37266. DOI PubMed PMC
38. Xiang S, Li J, Zhang M. TGF-β1 inhibitor enhances the therapeutic effect of microwave ablation on hepatocellular carcinoma. Int J
Hyperthermia. 2024;41:2359496. DOI PubMed
39. Chen Y, Bei J, Chen M, et al. Intratumoral lactate depletion based on injectable nanoparticles-hydrogel composite system synergizes
with immunotherapy against postablative hepatocellular carcinoma recurrence. Adv Healthc Mater. 2024;13:e2303031. DOI PubMed
40. Mizukoshi E, Yamashita T, Arai K, et al. Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency
ablation of hepatocellular carcinoma. Hepatology. 2013;57:1448-57. DOI PubMed